DE50002107D1 - ALPHA LIPONIC ACID (DERIVATIVES) CONTAINING RETARD FORM - Google Patents
ALPHA LIPONIC ACID (DERIVATIVES) CONTAINING RETARD FORMInfo
- Publication number
- DE50002107D1 DE50002107D1 DE50002107T DE50002107T DE50002107D1 DE 50002107 D1 DE50002107 D1 DE 50002107D1 DE 50002107 T DE50002107 T DE 50002107T DE 50002107 T DE50002107 T DE 50002107T DE 50002107 D1 DE50002107 D1 DE 50002107D1
- Authority
- DE
- Germany
- Prior art keywords
- derivatives
- liponic acid
- retard form
- alpha
- alpha liponic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE50002107T DE50002107D1 (en) | 1999-10-01 | 2000-09-29 | ALPHA LIPONIC ACID (DERIVATIVES) CONTAINING RETARD FORM |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19947330 | 1999-10-01 | ||
DE10045904A DE10045904B4 (en) | 1999-10-01 | 2000-09-16 | alpha-lipoic acid (derivatives) containing sustained release form |
PCT/EP2000/009585 WO2001024795A1 (en) | 1999-10-01 | 2000-09-29 | RETARD FORM CONTAINING α-LIPOIC ACID (DERIVATIVES) |
DE50002107T DE50002107D1 (en) | 1999-10-01 | 2000-09-29 | ALPHA LIPONIC ACID (DERIVATIVES) CONTAINING RETARD FORM |
Publications (1)
Publication Number | Publication Date |
---|---|
DE50002107D1 true DE50002107D1 (en) | 2003-06-12 |
Family
ID=7924166
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE10045904A Expired - Fee Related DE10045904B4 (en) | 1999-10-01 | 2000-09-16 | alpha-lipoic acid (derivatives) containing sustained release form |
DE50002107T Expired - Lifetime DE50002107D1 (en) | 1999-10-01 | 2000-09-29 | ALPHA LIPONIC ACID (DERIVATIVES) CONTAINING RETARD FORM |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE10045904A Expired - Fee Related DE10045904B4 (en) | 1999-10-01 | 2000-09-16 | alpha-lipoic acid (derivatives) containing sustained release form |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100708761B1 (en) |
DE (2) | DE10045904B4 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10305661A1 (en) * | 2003-02-12 | 2004-08-26 | Degussa Ag | Composition used for controlled, colon-specific release of alpha-lipoic acid or derivative, for treatment of inflammatory colon diseases, containing cationogenic polymer, organic acid and polymeric auxiliary |
KR100693613B1 (en) * | 2004-12-31 | 2007-03-14 | 부광약품 주식회사 | Composition for protecting hepatocyte containing silymarin and lipoic acid or its salts |
KR20090014568A (en) * | 2007-08-06 | 2009-02-11 | (주)바이오제닉스 | Coated alpha-lipoic acid particle, composition comprising the particle and method for preparing the particle |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0427246T3 (en) * | 1989-11-09 | 1995-11-27 | Asta Medica Ag | Drug containing, as active agent, sulfur-containing carboxylic acids and their use in the control of retroviruses |
DE59307753D1 (en) * | 1992-03-11 | 1998-01-15 | Asta Medica Ag | Tablets, granules and pellets with a high content of active ingredients for highly concentrated, solid dosage forms |
DE4413350A1 (en) * | 1994-04-18 | 1995-10-19 | Basf Ag | Retard matrix pellets and process for their production |
DE4433764A1 (en) * | 1994-09-22 | 1996-03-28 | Asta Medica Ag | Dosage forms containing alpha-lipoic acid, solid salts of R-thioctic acid with improved release and bioavailability |
-
2000
- 2000-09-16 DE DE10045904A patent/DE10045904B4/en not_active Expired - Fee Related
- 2000-09-29 DE DE50002107T patent/DE50002107D1/en not_active Expired - Lifetime
- 2000-09-29 KR KR1020027004162A patent/KR100708761B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE10045904A1 (en) | 2001-11-15 |
DE10045904B4 (en) | 2007-07-12 |
KR20020060186A (en) | 2002-07-16 |
KR100708761B1 (en) | 2007-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE04772B1 (en) | 3-Aryl-2-hydroxypropanoic acid derivative (I) | |
DE69907435D1 (en) | (4-sulfonylamine) tetrahydroxy-4-carboxylic acid hydroxamides | |
DK1244647T3 (en) | Quinzoline derivatives as VIGF inhibitors | |
NO20000885L (en) | 4-Phenyl-pyridine derivatives | |
DE69927969D1 (en) | CONTROLLED RELEASE OF LIPONIC ACID | |
NO20006116L (en) | New 3-arylpropionic acid derivatives and analogues | |
ATE419231T1 (en) | MONO-SUBSTITUTED 3-PROPYL-GAMMA-AMINOBUTTERIC ACID | |
ID29149A (en) | ADJUVAN COMPOSITION | |
NO20015701L (en) | 5-Phenyl-pyrimidine derivatives | |
NO20020596L (en) | Arylsulfonamide-substituted hydroxamic acid derivatives | |
HK1054038A1 (en) | Substituted n-benzyl-indol-3-yl gloyoxylic acid derivatives having an antitumural effect | |
DK1254118T3 (en) | Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives | |
DK1187815T3 (en) | 4-phenyl-pyrimidine derivatives | |
DE60006703D1 (en) | 4-HYDROXYBIPHENYLHYDRAZID DERIVATIVES | |
ATE339438T1 (en) | SUBSTANTIAL CRYSTALLINE FORM OF MELAGATRAN | |
DK1106174T3 (en) | Compositions containing fat-soluble vitamins | |
NO20025542D0 (en) | quinolonecarboxylic acid derivatives | |
ATE262517T1 (en) | THIOPYRANE DERIVATIVES AS MMP INHIBITORS | |
NO20022867D0 (en) | Syklopentenon derivatives | |
DE50002107D1 (en) | ALPHA LIPONIC ACID (DERIVATIVES) CONTAINING RETARD FORM | |
EE200100612A (en) | 1-Trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethyl-chroman derivatives | |
EE200100537A (en) | Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokines | |
DE59909774D1 (en) | 1-CYCLOALKYLPYRAZOLYL-BENZOYL DERIVATIVES | |
IL149864A0 (en) | Saccharin derivatives as orally active elastase inhibitors | |
SI1216043T1 (en) | Retard form containing alpha-lipoic acid (derivatives) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: ALZCHEM TROSTBERG GMBH, 83308 TROSTBERG, DE |